{
    "medicine_id": "7428b2861e631e4c2a3f285beb8cb096b30ceb20",
    "platform_id": "DB11755",
    "metadata": {
        "name": "Aemcolo 194 mg 1 Tablet delayed release",
        "composition": "194 mg 1 Tetrahydrocannabivarin",
        "clinical_particulars": {
            "therapeutic_indications": "THCV does not currently have any FDA Health Canada or EMA approved indications",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Compared to THC which demonstrates its effects through weak partial agonist activity at Cannabinoid 1 CB1R and Cannabinoid 2 CB2R receptors THCV acts as a CB1 antagonist and a partial agonist of CB2 A32477 Further evidence has also shown that THCV acts as an agonist of GPR55 and l \u03b1 lysophosphatidylinositol LPI A32974 Beyond the endocannabinoid system THCV has also been reported to activate 5HT1A receptors to produce an antipsychotic effect that has therapeutic potential for ameliorating some of the negative cognitive and positive symptoms of schizophrenia A32975 Furthermore THCV interacts with different transient receptor potential TRP channels including TRPV1 which may contribute to the analgesic anti inflammatory and anti cancer effects of cannabinoids and Cannabis extracts A32976",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00177",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Valsartan"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Ramipril"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Esmolol"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Torasemide"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Isradipine"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Olmesartan"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Chlorthalidone"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Nitroprusside"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Atenolol"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Timolol"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Treprostinil"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Amlodipine"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Nisoldipine"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Prazosin"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Fosinopril"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Metolazone"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Benazepril"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Bosentan"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Propranolol"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Enalapril"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Labetalol"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Mecamylamine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Losartan"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Moexipril"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Eplerenone"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Lisinopril"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Perindopril"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Fenoldopam"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Indapamide"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Tadalafil"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Quinapril"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Telmisartan"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Methyldopa"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Felodipine"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Diazoxide"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Terazosin"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Guanethidine"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Captopril"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Nadolol"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Bepridil"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Hydralazine"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Bevantolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Practolol"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Polythiazide"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Spirapril"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Mibefradil"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Tienilic acid"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Debrisoquine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Celiprolol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Nebivolol"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Temocapril"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Riociguat"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Macitentan"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Indenolol"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Trimazosin"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Nicorandil"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Manidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Selexipag"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Talinolol"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Imidapril"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Landiolol"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Delapril"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Esatenolol"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Cloranolol"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Cyclopenthiazide"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Epanolol"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Muzolimine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Xipamide"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Candesartan"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Furosemide"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may increase the central nervous system depressant CNS depressant activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the central nervous system depressant CNS depressant activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Hydrocodone"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "Hydroxyzine may increase the central nervous system depressant CNS depressant activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Tetrahydrocannabivarin can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Tetrahydrocannabivarin may increase the sedative activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Tetrahydrocannabivarin may increase the sedative activities of Pramipexole"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Tetrahydrocannabivarin may increase the sedative activities of Ropinirole"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Tetrahydrocannabivarin may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Rufinamide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Sodium oxybate may increase the central nervous system depressant CNS depressant activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "The risk or severity of hypertension can be increased when Desmopressin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of hypertension can be increased when Cyclosporine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of hypertension can be increased when Icosapent is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The risk or severity of hypertension can be increased when Phentermine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of hypertension can be increased when Midodrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "The risk or severity of hypertension can be increased when Bethanidine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The risk or severity of hypertension can be increased when Isoetharine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of hypertension can be increased when Mesalazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of hypertension can be increased when Indomethacin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of hypertension can be increased when Norepinephrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The risk or severity of hypertension can be increased when Phenylephrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "The risk or severity of hypertension can be increased when Methylphenidate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of hypertension can be increased when Nabumetone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of hypertension can be increased when Ketorolac is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of hypertension can be increased when Tenoxicam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of hypertension can be increased when Celecoxib is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The risk or severity of hypertension can be increased when Buspirone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of hypertension can be increased when Tolmetin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The risk or severity of hypertension can be increased when Rofecoxib is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of hypertension can be increased when Piroxicam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00561",
                        "description": "The risk or severity of hypertension can be increased when Doxapram is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of hypertension can be increased when Fenoprofen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of hypertension can be increased when Valdecoxib is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of hypertension can be increased when Diclofenac is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of hypertension can be increased when Sulindac is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of hypertension can be increased when Metaraminol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The risk or severity of hypertension can be increased when Guanabenz is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The risk or severity of hypertension can be increased when Epinephrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "The risk or severity of hypertension can be increased when Phentolamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of hypertension can be increased when Flurbiprofen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of hypertension can be increased when Methoxamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of hypertension can be increased when Etodolac is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of hypertension can be increased when Mefenamic acid is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of hypertension can be increased when Naproxen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of hypertension can be increased when Sulfasalazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "The risk or severity of hypertension can be increased when Tolazoline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The risk or severity of hypertension can be increased when Phenylbutazone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of hypertension can be increased when Meloxicam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The risk or severity of hypertension can be increased when Orciprenaline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of hypertension can be increased when Carprofen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of hypertension can be increased when Phenmetrazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "The risk or severity of hypertension can be increased when Dobutamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of hypertension can be increased when Diflunisal is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The risk or severity of hypertension can be increased when Ritodrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of hypertension can be increased when Terbutaline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of hypertension can be increased when Omapatrilat is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The risk or severity of hypertension can be increased when Bitolterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The risk or severity of hypertension can be increased when Phenoxybenzamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of hypertension can be increased when Oxymetazoline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of hypertension can be increased when Salicylic acid is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of hypertension can be increased when Salmeterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of hypertension can be increased when Formoterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The risk or severity of hypertension can be increased when Dopamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of hypertension can be increased when Oxaprozin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of hypertension can be increased when Salbutamol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of hypertension can be increased when Ketoprofen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of hypertension can be increased when Balsalazide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of hypertension can be increased when Ibuprofen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The risk or severity of hypertension can be increased when Isoprenaline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The risk or severity of hypertension can be increased when Arbutamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The risk or severity of hypertension can be increased when Dutasteride is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of hypertension can be increased when Rescinnamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of hypertension can be increased when Propafenone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The risk or severity of hypertension can be increased when Finasteride is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of hypertension can be increased when Olsalazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of hypertension can be increased when Arformoterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of hypertension can be increased when Lumiracoxib is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of hypertension can be increased when Fenoterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The risk or severity of hypertension can be increased when Pirbuterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of hypertension can be increased when Ephedrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of hypertension can be increased when Mephentermine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The risk or severity of hypertension can be increased when Procaterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of hypertension can be increased when Salsalate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The risk or severity of hypertension can be increased when Clenbuterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "The risk or severity of hypertension can be increased when Bambuterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of hypertension can be increased when Antrafenine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of hypertension can be increased when Aminophenazone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of hypertension can be increased when Antipyrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The risk or severity of hypertension can be increased when 2 5 Dimethoxy 4 ethylamphetamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The risk or severity of hypertension can be increased when Chlorphentermine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The risk or severity of hypertension can be increased when Phendimetrazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The risk or severity of hypertension can be increased when Etoricoxib is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB02032",
                        "description": "The risk or severity of hypertension can be increased when Epicaptopril is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of hypertension can be increased when Taxifolin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04581",
                        "description": "The risk or severity of hypertension can be increased when 1 benzylimidazole is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of hypertension can be increased when Nimesulide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of hypertension can be increased when Benoxaprofen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of hypertension can be increased when Metamizole is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of hypertension can be increased when Zomepirac is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The risk or severity of hypertension can be increased when Dronedarone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of hypertension can be increased when Cimicoxib is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The risk or severity of hypertension can be increased when Amibegron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of hypertension can be increased when Nylidrin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The risk or severity of hypertension can be increased when Solabegron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The risk or severity of hypertension can be increased when Xylometazoline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The risk or severity of hypertension can be increased when Isometheptene is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of hypertension can be increased when Levonordefrin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of hypertension can be increased when Naphazoline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of hypertension can be increased when Lornoxicam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of hypertension can be increased when Aceclofenac is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of hypertension can be increased when Zaltoprofen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The risk or severity of hypertension can be increased when Saralasin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of hypertension can be increased when Tetryzoline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of hypertension can be increased when Azapropazone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of hypertension can be increased when Parecoxib is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of hypertension can be increased when Salicylamide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of hypertension can be increased when Tyramine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The risk or severity of hypertension can be increased when Adrafinil is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of hypertension can be increased when Kebuzone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of hypertension can be increased when Isoxsuprine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of hypertension can be increased when Isoxicam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "The risk or severity of hypertension can be increased when Indoramin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of hypertension can be increased when Indoprofen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of hypertension can be increased when Ibuproxam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The risk or severity of hypertension can be increased when Hexoprenaline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of hypertension can be increased when Floctafenine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of hypertension can be increased when Fenbufen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of hypertension can be increased when Etofenamate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of hypertension can be increased when Etilefrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of hypertension can be increased when Epirizole is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of hypertension can be increased when Olodaterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of hypertension can be increased when Benzydamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The risk or severity of hypertension can be increased when Cirazoline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of hypertension can be increased when Synephrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "The risk or severity of hypertension can be increased when Moxisylyte is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of hypertension can be increased when Dexibuprofen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of hypertension can be increased when Dexketoprofen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of hypertension can be increased when Droxicam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of hypertension can be increased when Tolfenamic acid is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of hypertension can be increased when Firocoxib is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of hypertension can be increased when Clonixin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The risk or severity of hypertension can be increased when Moxonidine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The risk or severity of hypertension can be increased when Doxofylline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of hypertension can be increased when Morniflumate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of hypertension can be increased when Propacetamol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of hypertension can be increased when Talniflumate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The risk or severity of hypertension can be increased when Iofetamine I 123 is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of hypertension can be increased when Racepinephrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "The risk or severity of hypertension can be increased when DL Methylephedrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The risk or severity of hypertension can be increased when Amitraz is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of hypertension can be increased when Robenacoxib is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of hypertension can be increased when Tepoxalin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11481",
                        "description": "The risk or severity of hypertension can be increased when Atipamezole is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of hypertension can be increased when Flunixin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The risk or severity of hypertension can be increased when Ractopamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "The risk or severity of hypertension can be increased when Etafedrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "The risk or severity of hypertension can be increased when Rilmenidine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Anisodamine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with PF 00610355"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Abediterol"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Siponimod"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Nitroaspirin"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Indobufen"
                    },
                    {
                        "drugbank-id": "DB12551",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Idazoxan"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Ebselen"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Reproterol"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Theodrenaline"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Tinoridine"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Tramazoline"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Alclofenac"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Fentiazac"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Suxibuzone"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Octopamine"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Bumadizone"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Alminoprofen"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Fenozolone"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Difenpiramide"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Nifenazone"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Lonazolac"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Xenon"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Tenidap"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Buflomedil"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Propyphenazone"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Proglumetacin"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Guacetisal"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Ethenzamide"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Carbaspirin calcium"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Mofebutazone"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Proquazone"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Benorilate"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Pirprofen"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Xamoterol"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Acemetacin"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Imidazole salicylate"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Deoxyepinephrine"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with SC 236"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with NS 398"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Quinoline Yellow WS"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of hypertension can be increased when Loxoprofen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Tetrahydrocannabivarin may increase the hypertensive activities of Droxidopa"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Trazodone"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Trospium"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Benzatropine"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Metixene"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Buclizine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Profenamine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Atropine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Biperiden"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Cocaine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Quinidine"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Tolterodine"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Tiotropium"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Solifenacin"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Aclidinium"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Revefenacin"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Propiverine"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Otilonium"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Timepidium"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Tryptophan is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Baclofen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when Lorazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of adverse effects can be increased when Succinylcholine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Reserpine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of adverse effects can be increased when Eletriptan is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when Enflurane is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Temazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Reboxetine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Butabarbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of adverse effects can be increased when Butalbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The risk or severity of adverse effects can be increased when Phenytoin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of adverse effects can be increased when Topiramate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of adverse effects can be increased when Clemastine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of adverse effects can be increased when Atomoxetine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of adverse effects can be increased when Etomidate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Talbutal is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of adverse effects can be increased when Pentobarbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of adverse effects can be increased when Valproic acid is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Codeine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when Tolcapone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Hydromorphone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Olanzapine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of adverse effects can be increased when Cetirizine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of adverse effects can be increased when Protriptyline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of adverse effects can be increased when Trimethadione is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The risk or severity of adverse effects can be increased when Clobazam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of adverse effects can be increased when Clozapine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Meprobamate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when Palonosetron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of adverse effects can be increased when Sulpiride is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Alprazolam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when Loxapine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The risk or severity of adverse effects can be increased when Remoxipride is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of adverse effects can be increased when Secobarbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of adverse effects can be increased when Promazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when Methocarbamol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of adverse effects can be increased when Triprolidine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when Meperidine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of adverse effects can be increased when Imipramine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Metharbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of adverse effects can be increased when Quinine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The risk or severity of adverse effects can be increased when Methohexital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The risk or severity of adverse effects can be increased when Entacapone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when Oxycodone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of adverse effects can be increased when Triflupromazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when Mephenytoin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of adverse effects can be increased when Nortriptyline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of adverse effects can be increased when Amoxapine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Adinazolam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of adverse effects can be increased when Lamotrigine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of adverse effects can be increased when Carbamazepine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Cisatracurium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of adverse effects can be increased when Fenfluramine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Mazindol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of adverse effects can be increased when Ethosuximide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of adverse effects can be increased when Thiopental is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of adverse effects can be increased when Cisapride is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when Butorphanol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when Paramethadione is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of adverse effects can be increased when Efavirenz is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when Dyclonine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when Pentazocine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of adverse effects can be increased when Metaxalone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of adverse effects can be increased when Sumatriptan is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of adverse effects can be increased when Thioridazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of adverse effects can be increased when Moricizine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when Midazolam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Flurazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of adverse effects can be increased when Tizanidine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Sufentanil is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be increased when Apomorphine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of adverse effects can be increased when Trimipramine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when Rocuronium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when Risperidone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when Meclizine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of adverse effects can be increased when Riluzole is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of adverse effects can be increased when Scopolamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Isoflurane is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The risk or severity of adverse effects can be increased when Ethotoin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of adverse effects can be increased when Dolasetron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of adverse effects can be increased when Clidinium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The risk or severity of adverse effects can be increased when Propiomazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of adverse effects can be increased when Primidone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Halazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Alfentanil is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when Fentanyl is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of adverse effects can be increased when Propofol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Acetazolamide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when Diazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when Phensuximide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of adverse effects can be increased when Brompheniramine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when Progabide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Oxazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when Donepezil is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of adverse effects can be increased when Perphenazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Levorphanol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The risk or severity of adverse effects can be increased when Benzphetamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of adverse effects can be increased when Alprenolol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of adverse effects can be increased when Flupentixol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of adverse effects can be increased when Granisetron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Triazolam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Remifentanil is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when Tiagabine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when Zonisamide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of adverse effects can be increased when Almotriptan is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The risk or severity of adverse effects can be increased when Diethylpropion is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Hexafluronium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of adverse effects can be increased when Felbamate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of adverse effects can be increased when Naratriptan is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of adverse effects can be increased when Rizatriptan is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of adverse effects can be increased when Pindolol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when Zaleplon is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of adverse effects can be increased when Desloratadine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The risk or severity of adverse effects can be increased when Alosetron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The risk or severity of adverse effects can be increased when Ramelteon is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when Gabapentin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of adverse effects can be increased when Frovatriptan is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Guanfacine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of adverse effects can be increased when Acetophenazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The risk or severity of adverse effects can be increased when Melatonin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Clonazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of adverse effects can be increased when Promethazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when Vigabatrin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of adverse effects can be increased when Pimozide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when Methyprylon is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when Phenacemide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The risk or severity of adverse effects can be increased when Doxacurium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of adverse effects can be increased when Doxepin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of adverse effects can be increased when Desipramine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The risk or severity of adverse effects can be increased when Thiamylal is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of adverse effects can be increased when Bupropion is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Halothane is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The risk or severity of adverse effects can be increased when Phenobarbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of adverse effects can be increased when Cyclizine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Chlormezanone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when Desflurane is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Oxymorphone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Tubocurarine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when Levetiracetam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Dezocine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Estazolam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of adverse effects can be increased when Dantrolene is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of adverse effects can be increased when Ketamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of adverse effects can be increased when Quetiapine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of adverse effects can be increased when Mivacurium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of adverse effects can be increased when Levodopa is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Sevoflurane is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of adverse effects can be increased when Aripiprazole is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of adverse effects can be increased when Clomipramine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when Decamethonium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of adverse effects can be increased when Alimemazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of adverse effects can be increased when Paliperidone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of adverse effects can be increased when St John s Wort is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when Pancuronium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of adverse effects can be increased when Pipecuronium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Vecuronium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of adverse effects can be increased when Amobarbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The risk or severity of adverse effects can be increased when Aprobarbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Butobarbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Heptabarbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Hexobarbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of adverse effects can be increased when Penbutolol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when Yohimbine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when Glutethimide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when gamma Hydroxybutyric acid is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The risk or severity of adverse effects can be increased when MMDA is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Bufotenine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Diamorphine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The risk or severity of adverse effects can be increased when Midomafetamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Fencamfamin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of adverse effects can be increased when 4 Methoxyamphetamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of adverse effects can be increased when Barbital is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of adverse effects can be increased when 4 Bromo 2 5 dimethoxyamphetamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Dimethyltryptamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Camazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Etorphine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when Difenoxin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Delorazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Dextromoramide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Desomorphine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when Chlorhexadol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Carfentanil is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when Drotebanol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Cloxazolam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Bromazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Clotiazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Cathinone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Dihydromorphine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Fludiazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The risk or severity of adverse effects can be increased when Metamfetamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of adverse effects can be increased when Oxprenolol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when Ketazolam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Prazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Quazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Cinolazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Nitrazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of adverse effects can be increased when Periciazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of adverse effects can be increased when Acepromazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of adverse effects can be increased when Aceprometazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Alverine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The risk or severity of adverse effects can be increased when Molindone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of adverse effects can be increased when Pipotiazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of adverse effects can be increased when Thioproperazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of adverse effects can be increased when Thiothixene is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Rolipram is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when 7 Nitroindazole is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when S Ethylisothiourea is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when Domoic Acid is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Oxitriptan is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Phencyclidine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when Valpromide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Phenethylamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Aniracetam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when Methapyrilene is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Nomifensine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when Urethane is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when Methaqualone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when Amineptine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of adverse effects can be increased when Flunarizine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of adverse effects can be increased when Fluspirilene is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The risk or severity of adverse effects can be increased when Lorcaserin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Osanetant is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Cilansetron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when Bifeprunox is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when Pagoclone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of adverse effects can be increased when Flibanserin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Renzapride is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of adverse effects can be increased when Iloperidone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of adverse effects can be increased when Ezogabine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when APD791 is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of adverse effects can be increased when Methsuximide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when Pimavanserin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when Brivaracetam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Naronapride is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of adverse effects can be increased when Naluzotan is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when PRX 08066 is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of adverse effects can be increased when BL 1020 is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Gantacurium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of adverse effects can be increased when Cariprazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when Lumateperone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when YKP 1358 is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Sertindole is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of adverse effects can be increased when Mianserin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of adverse effects can be increased when Pizotifen is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of adverse effects can be increased when Asenapine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The risk or severity of adverse effects can be increased when Lacosamide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when Tolperisone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of adverse effects can be increased when Levocetirizine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of adverse effects can be increased when Ziconotide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of adverse effects can be increased when Amisulpride is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when Dotarizine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The risk or severity of adverse effects can be increased when Remacemide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when Clomethiazole is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Deramciclane is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when Tramiprosate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when Ocinaplon is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when Gaboxadol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Adipiplon is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Dextofisopam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The risk or severity of adverse effects can be increased when Agomelatine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Saredutant is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Esmirtazapine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The risk or severity of adverse effects can be increased when Vilazodone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when Fospropofol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Ketobemidone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when Triclofos is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when Mebutamate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Wortmannin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when Sulthiame is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of adverse effects can be increased when Cinitapride is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The risk or severity of adverse effects can be increased when Tofisopam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when Lurasidone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Serotonin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when DPDPE is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when Arbaclofen Placarbil is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when Perospirone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Amperozide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of adverse effects can be increased when Ifenprodil is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Hexamethonium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Etifoxine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of adverse effects can be increased when Eperisone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of adverse effects can be increased when Dimetacrine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of adverse effects can be increased when Cyamemazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The risk or severity of adverse effects can be increased when Barbexaclone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when Beclamide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Captodiame is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of adverse effects can be increased when Butriptyline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Brotizolam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when Benzoctamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when Benactyzine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of adverse effects can be increased when Vortioxetine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The risk or severity of adverse effects can be increased when Tasimelteon is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The risk or severity of adverse effects can be increased when Stiripentol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The risk or severity of adverse effects can be increased when Eslicarbazepine acetate is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Etizolam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of adverse effects can be increased when Dosulepin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Lofentanil is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Edivoxetine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when Viloxazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Nisoxetine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Lortalamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Talopram is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when Etoperidone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when Blonanserin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of adverse effects can be increased when Melperone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Zotepine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Brilaroxazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Iproclozide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Pipamperone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of adverse effects can be increased when Tianeptine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of adverse effects can be increased when Ramosetron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when Oxaprotiline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when Opium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when Pyrantel is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when Alfaxalone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The risk or severity of adverse effects can be increased when Azaperone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The risk or severity of adverse effects can be increased when Doramectin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of adverse effects can be increased when Medetomidine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of adverse effects can be increased when Xylazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of adverse effects can be increased when Propiopromazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of adverse effects can be increased when Romifidine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when Tiletamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when Tricaine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Zolazepam is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of adverse effects can be increased when Detomidine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when Thiocolchicoside is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Normethadone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Psilocybin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Mosapride is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Iferanserin is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when Tropisetron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Benperidol"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Lithium carbonate"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Pyrazolam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "Methysergide may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "Cabergoline may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "Methylergometrine may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "Lisuride may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "Ergotamine may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "Nicergoline may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "Pergolide may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Bromocriptine may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "Ergometrine may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "Lysergic acid diethylamide may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "Dihydroergocornine may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "Dihydroergocryptine may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "Terguride may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "Metergoline may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Amphetamine"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Linezolid"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Furazolidone"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Procaine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Minaprine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Isocarboxazid"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Rasagiline"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Pargyline"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Clorgiline"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Nialamide"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The metabolism of Tetrahydrocannabivarin can be decreased when combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Tetrahydrocannabivarin can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Tetrahydrocannabivarin can be increased when used in combination with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The therapeutic efficacy of Tetrahydrocannabivarin can be decreased when used in combination with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of hypertension can be increased when Esketamine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of hypertension can be increased when Solriamfetol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the hypertensive activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Tetrahydrocannabivarin is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of sedation can be increased when Metoclopramide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of adverse effects can be increased when Lasmiditan is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of CNS depression can be increased when Tramadol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of adverse effects can be increased when Ziprasidone is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of CNS depression can be increased when Haloperidol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of vasospastic reactions can be increased when Zolmitriptan is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of sedation can be increased when Tetrahydrocannabivarin is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Tetrahydrocannabivarin is combined with Oliceridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}